SYNbiotics Easing Renal failure by improving Gut microbiologY (SYNERGY): a protocol of placebo-controlled randomised cross-over trial

BACKGROUND: Emerging evidence suggests modulating the microbiota in the large bowel of patients with chronic kidney disease (CKD) through pre- and/probiotic supplementation may inhibit the development of key nephrovascular toxins. To date, quality intervention trials investigating this novel treatme...

Descripción completa

Detalles Bibliográficos
Autores principales: Rossi, Megan, Johnson, David W, Morrison, Mark, Pascoe, Elaine, Coombes, Jeff S, Forbes, Josephine M, McWhinney, Brett C, Ungerer, Jacobus PJ, Dimeski, Goce, Campbell, Katrina L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4094543/
https://www.ncbi.nlm.nih.gov/pubmed/24996842
http://dx.doi.org/10.1186/1471-2369-15-106

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4094543/
https://www.ncbi.nlm.nih.gov/pubmed/24996842
http://dx.doi.org/10.1186/1471-2369-15-106

Ejemplares similares